In Search of TGCT Biomarkers: A Comprehensive In Silico and Histopathological Analysis
Authors:
- Dora RaosDRDora Raos
- Jure KrasicJKJure Krasic
- Silvija MasicSMSilvija Masic
- Irena AbramovicIAIrena Abramovic
- Marijana CoricMCMarijana Coric
- Bozo KruslinBKBozo Kruslin
- Ana Katusic BojanacABAna Katusic Bojanac
- Floriana Bulic-JakusFBFloriana Bulic-Jakus
- Davor JezekDJDavor Jezek
- Monika UlamecMUMonika Ulamec
- Nino SincicNSNino Sincic
Open Access
- 5 November 2020
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2020, 1-18
Abstract
Testicular germ cell tumors (TGCTs) are ever more affecting the young male population. Germ cell neoplasia in situ (GCNIS) is the origin of TGCTs, namely, seminomas (SE) and a heterogeneous group of nonseminomas (NS) comprising embryonal carcinoma, teratoma, yolk sac tumor, and choriocarcinoma. Response to the treatment and prognosis, especially of NS, depend on precise diagnosis with a necessity for discovery of new biomarkers. We aimed to perform comprehensive in silico analysis at the DNA, RNA, and protein levels of six prospective (HOXA9, MGMT, CFC1, PRSS21, RASSF1A, and MAGEC2) and six known TGCT biomarkers (OCT4, SOX17, SOX2, SALL4, NANOG, and KIT) and assess its congruence with histopathological analysis in all forms of TGCTs. Cancer Hallmarks Analytics Tool, the Search Tool for the Retrieval of Interacting Genes/Proteins database, and UALCAN, an interactive web resource for analyzing cancer OMICS data, were used. In 108 TGCT and 48 tumor-free testicular samples, the immunoreactivity score (IRS) was calculated. SE showed higher frequency in DNA alteration, while DNA methylation was significantly higher for all prospective biomarkers in NS. In GCNIS, we assessed the clinical positivity of RASSF1 and PRSS21 in 52 and 62 of samples, respectively, in contrast to low or nil positivity in healthy seminiferous tubules, TGTCs as a group, SE, NS, or all NS components. Although present in approximately 80 of healthy seminiferous tubules (HT) and GCNIS, HOXA9 was diagnostically positive in 64 of TGCTs, while it was positive in 82 of NS versus 29 of SE. Results at the DNA, mRNA, and protein levels on putative and already known biomarkers were included in the suggested panels that may prove to be important for better diagnostics of various forms of TGCTs.Keywords
Funding Information
- National Institutes of Health (KK.01.1.1.01.0008, IP-2016-06-36-92)
- National Cancer Institute (KK.01.1.1.01.0008, IP-2016-06-36-92)
- National Human Genome Research Institute (KK.01.1.1.01.0008, IP-2016-06-36-92)
- National Heart, Lung, and Blood Institute (KK.01.1.1.01.0008, IP-2016-06-36-92)
- National Institute on Drug Abuse (KK.01.1.1.01.0008, IP-2016-06-36-92)
- National Institute of Mental Health (KK.01.1.1.01.0008, IP-2016-06-36-92)
- National Institute of Neurological Disorders and Stroke (KK.01.1.1.01.0008, IP-2016-06-36-92)
- European Commission (KK.01.1.1.01.0008, IP-2016-06-36-92)
- Hrvatska Zaklada za Znanost (KK.01.1.1.01.0008, IP-2016-06-36-92)
This publication has 70 references indexed in Scilit:
- SALL4 is a useful marker in the diagnostic work-up of germ cell tumors in extra-testicular locationsVirchows Archiv, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- Testicular cancer: A narrative review of the role of socioeconomic position from risk to survivorshipUrologic Oncology: Seminars and Original Investigations, 2012
- Impact of classification of mixed germ-cell tumours on incidence trends of non-seminomaInternational Journal of Andrology, 2011
- OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogoniaThe Journal of Pathology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Serum human chorionic gonadotropin is associated with angiogenesis in germ cell testicular tumorsJournal of Experimental & Clinical Cancer Research, 2009
- Whole brain radiotherapy with radiosensitizer for brain metastasesJournal of Experimental & Clinical Cancer Research, 2009
- Testicular germ-cell tumours in a broader perspectiveNature Reviews Cancer, 2005
- Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumorsOncogene, 2002